Emami Q1 FY27 Results: Revenue Up 15% to ₹1,039 Crore; Domestic Business Grows 20%

What Happened ?

Emami Limited reported Q1 FY27 consolidated revenue from operations of ₹1,039 crore, up 15% YoY. Domestic business grew 20%, with like-to-like growth of 12% and volume growth of 8%. EBITDA grew 6% to ₹226 crore despite sharp input cost inflation. PAT stood at ₹137 crore, impacted by higher tax expense. The company increased stake in Axiom Ayurveda (AloFrut) making it a wholly owned subsidiary, and acquired majority stake in IncNut (Vedix and SkinKraft).

key details

• Revenue from operations up 15% YoY to ₹1,039 crore.
• Domestic business up 20% YoY; like-to-like growth of 12% with 8% volume growth.
• International business declined 12% due to West Asia disruptions.
• EBITDA up 6% YoY to ₹226 crore; PBT up 4% YoY to ₹195 crore.
• Strategic investments portfolio grew 61% (like-to-like); now contributes ~18% of domestic business.
• Organised channels grew 19% (like-to-like); now contribute 32% of domestic business.
• Quick Commerce contributes 35% of E-commerce sales.
• Hair & Scalp Care grew 11%; Skin Care grew 3%; Health Care grew 2%.
• Gross margins contracted 360 bps to 65.8% due to higher input costs.
• Strategic acquisitions: Increased stake in Axiom Ayurveda (wholly owned subsidiary); acquired majority stake in IncNut (Vedix, SkinKraft).

Note:

• The quarter was marked by elevated crude prices, inflationary pressures, and West Asia conflict disruptions.
• Gross margins contracted due to higher crude oil prices and inflation across packaging materials.
• Despite this, EBITDA and PBT grew through disciplined cost management and operational efficiencies.
• The company’s channel transformation continues with organised channels contributing 32% of domestic business.

Risk Analysis

Summary:

• While the company delivered strong domestic growth, risks include geopolitical disruptions, commodity inflation, and competitive intensity.

Key Risks:

• Geopolitical disruptions in West Asia impacting international business.
• Commodity price volatility (crude oil, packaging materials) impacting margins.
• Currency fluctuations affecting international operations.
• Competition in personal care and healthcare categories.
• Integration of acquired businesses (Axiom Ayurveda, IncNut).
• Changing consumer preferences and demand patterns.

Worst Case:

Sustained geopolitical tensions or commodity inflation could continue to pressure margins and international business performance.

Risk Level: Medium

Company Commentary

Management highlighted that:

• Mr Harsha V Agarwal, Vice Chairman and Managing Director, Emami Limited: “We delivered another quarter of strong performance despite a challenging operating environment marked by geopolitical disruptions, elevated inflationary pressures and an uneven summer season across markets.”
• “Our Domestic Business grew 20%, driving overall revenue growth of 15%, reflecting the strength of our brands and execution capabilities.”
• “We are particularly encouraged by the growing contribution of our Strategic Investments portfolio, which now accounts for nearly 18% of our domestic business, reinforcing our strategy of building multiple growth engines alongside our trusted core brands.”
• “As we invest for the future, digital and AI are increasingly becoming core enablers of our growth strategy. By embedding these capabilities across our value chain, we are strengthening execution, improving agility and building a future-ready organisation that is well positioned to deliver sustained, profitable growth.”
• Mr Mohan Goenka, Vice Chairman and Whole-Time Director, Emami Limited: “The quarter tested the resilience of our operating model as elevated input costs continued to exert pressure on margins. Despite this, our focus on disciplined execution, cost optimisation and operational agility enabled us to deliver EBITDA growth of 6% to 226 crore and PBT growth of 4% to 195 crore.”
• “We also continued to make steady progress on our channel transformation agenda, with organised channels growing 19% and contributing 32% of our domestic business.”
• “As input cost pressures begin to ease and our innovation pipeline gains momentum, we remain well positioned to strengthen profitability while sustaining growth across our businesses.”